BLACKBERRY Ltd: Form 10-Q for the period ended Nov 30, 2020
Filed with the SEC on Dec 18, 2020 and accepted by EDGAR at Dec 18, 2020, 16:32 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-11-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-09-01 to 2020-11-30 | $218.0m | us-gaap:Revenues |
| Revenue | 9 months2020-03-01 to 2020-11-30 | $683.0m | us-gaap:Revenues |
| Cost of revenue | 3 months2020-09-01 to 2020-11-30 | $69.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2020-03-01 to 2020-11-30 | $192.0m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2020-09-01 to 2020-11-30 | $149.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-03-01 to 2020-11-30 | $491.0m | us-gaap:GrossProfit |
| Research and development | 3 months2020-09-01 to 2020-11-30 | $53.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-03-01 to 2020-11-30 | $167.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-09-01 to 2020-11-30 | $83.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-03-01 to 2020-11-30 | $252.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-09-01 to 2020-11-30 | −$127.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-03-01 to 2020-11-30 | −$794.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-09-01 to 2020-11-30 | $2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-03-01 to 2020-11-30 | −$11.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-09-01 to 2020-11-30 | −$130.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-03-01 to 2020-11-30 | −$789.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-09-01 to 2020-11-30 | −$0.23 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-03-01 to 2020-11-30 | −$1.41 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-09-01 to 2020-11-30 | −$0.23 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-03-01 to 2020-11-30 | −$1.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-09-01 to 2020-11-30 | 562,443,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-03-01 to 2020-11-30 | 559,732,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-03-01 to 2020-11-30 | $30.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-03-01 to 2020-11-30 | $5.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-11-30 | $223.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-11-30 | $971.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-11-30 | $2.87bn | us-gaap:Assets |
| Current liabilities | At period end2020-11-30 | $427.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-11-30 | $1.07bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-11-30 | $1.80bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001070235-20-000160. Last ingested by Listed: Nov 5, 2026, 18:44 ET. Listed shows no prices and gives no investment advice.